🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 122 of 151

  1. TAK-341

    Takeda

    Multiple System Atrophy

    phase 2 small molecule completed

    1 trial

  2. TAK-360

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule active

    1 trial

  3. TAK-360

    Takeda

    Idiopathic Hypersomnia

    phase 2 small molecule active

    1 trial

  4. TAK-379

    Takeda

    Diabetes Mellitus

    phase 2 small molecule terminated

    1 trial

  5. TAK-385

    Takeda

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  6. TAK-385

    Takeda

    Uterine Fibroids

    phase 2 small molecule completed

    1 trial

  7. TAK-411

    Takeda

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

    phase 2 mab active

    1 trial

  8. TAK-442

    Takeda

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  9. TAK-442

    Takeda

    Acute Coronary Syndrome

    phase 2 small molecule completed

    1 trial

  10. TAK-448

    Takeda

    Hypogonadotropic Hypogonadism

    phase 2 small molecule terminated

    1 trial

  11. TAK-448

    Takeda

    Low Testosterone

    phase 2 small molecule terminated

    1 trial

  12. TAK-500

    Takeda

    Pancreatic Cancer

    phase 2 small molecule terminated

    1 trial

  13. TAK-505

    Takeda

    Malignant Solid Tumors

    phase 2 small molecule active

    1 trial

  14. TAK-583

    Takeda

    Diabetic Neuropathies

    phase 2 small molecule completed

    1 trial

  15. TAK-653

    Takeda

    Treatment-Resistant Depression

    phase 2 small molecule terminated

    1 trial

  16. TAK-659

    Takeda

    AML

    phase 2 small molecule terminated

    1 trial

  17. TAK-662

    Takeda

    Congenital Protein C Deficiency

    phase 2 small molecule completed

    1 trial

  18. TAK-700

    Takeda

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  19. TAK-715 and methotrexate

    Takeda

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  20. TAK-755

    Takeda

    Acute Ischemic Stroke

    phase 2 mab active

    1 trial

  21. TAK-783 and methotrexate

    Takeda

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  22. TAK-788

    Takeda

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule terminated

    1 trial

  23. TAK-788

    Takeda

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule active

    1 trial

  24. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Friedreich Ataxia

    phase 2 small molecule completed

    1 trial

  25. TAK-850

    Takeda

    Influenza Prevention

    phase 2 small molecule terminated

    1 trial

  26. TAK-850

    Takeda

    Influenza Infection

    phase 2 mab completed

    1 trial

  27. TAK-850

    Takeda

    Influenza

    phase 2 small molecule completed

    1 trial

  28. TAK-850 0.5 mL injection

    Takeda

    Influenza Infection

    phase 2 small molecule completed

    1 trial

  29. TAK-853

    Takeda

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  30. TAK-906 Maleate

    Takeda

    Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis

    phase 2 small molecule completed

    1 trial

  31. TAK-906 Maleate

    Takeda

    Diabetic Gastroparesis

    phase 2 small molecule completed

    1 trial

  32. TAK-919

    Takeda

    Coronavirus Disease (COVID-19)

    phase 2 mab completed

    1 trial

  33. TAK-931

    Takeda

    Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  34. TAK-935

    Takeda

    Developmental and/or Epileptic Encephalopathies

    phase 2 small molecule completed

    1 trial

  35. TAK-935

    Takeda

    Epilepsy

    phase 2 small molecule completed

    2 trials

  36. TAK-951

    Takeda

    Postoperative Nausea and Vomiting (PONV)

    phase 2 small molecule completed

    1 trial

  37. TAK-954

    Takeda

    Diabetic Gastroparesis

    phase 2 small molecule completed

    1 trial

  38. TAK-954

    Takeda

    Critical Illness

    phase 2 small molecule terminated

    1 trial

  39. TAK-954 Placebo

    Takeda

    Postoperative Gastrointestinal Dysfunction

    phase 2 small molecule completed

    1 trial

  40. TAK-981

    Takeda

    Lymphoma, Non-Hodgkin

    phase 2 small molecule terminated

    1 trial

  41. TAK-981

    Takeda

    Neoplasms

    phase 2 small molecule terminated

    1 trial

  42. TAK-981

    Takeda

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 2 small molecule terminated

    1 trial

  43. TAK-981

    Takeda

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule completed

    1 trial

  44. TAK-994

    Takeda

    Narcolepsy Type 1 (NT 1)

    phase 2 small molecule terminated

    1 trial

  45. TAK-994

    Takeda

    Narcolepsy Type 1 (NT1)

    phase 2 small molecule terminated

    1 trial

  46. TAK228

    Takeda

    Lymphoma

    phase 2 small molecule terminated

    1 trial

  47. TAMBICICLIB 100 mg/10 mL, Solution for Injection, AZACITIDINE , TAMBICICLIB 100 mg/20 mL, Solution for Injection, VENETOCLAX

    Istituto Gentili S.r.l.

    Acute myeloid leukemia

    phase 2 small molecule active

    1 trial

  48. TAMOXENE 20 mg compresse rivestite con film

    Verona Pharma Ireland Limited

    cystic fibrosis

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.